Perceptions, intentions, and actual use of a consumer nicotine gum
- PMID: 37700314
- PMCID: PMC10498549
- DOI: 10.1186/s12954-023-00864-0
Perceptions, intentions, and actual use of a consumer nicotine gum
Abstract
Background: Little is known about perceptions, use intentions, and behaviors of adults regarding nicotine gum that is marketed and regulated as a consumer product rather than as a medicinal nicotine replacement therapy (NRT).
Methods: Survey data were collected from a Qualtrics online panel (N = 1000) of adults who had never used a consumer nicotine gum, recruited based on smoking behavior, and from current and former purchasers of one commercially available nicotine gum product (LUCY Chew and Park), recruited via emails to a customer database (N = 500). In addition to descriptive cross-sectional analyses, logistic regression was used to estimate the probability of intent to try and of product appeal among these different groups.
Results: Among online panel respondents, individuals who smoked with and without plans to quit showed high intention to try the product (odds ratios 15.6 [95% CI 9.3, 27.6] and 9.8 [95% CI 5.8, 17.3] respectively, compared to people who formerly smoked) and persons who had never smoked showed low intentions to try. These results stood regardless of flavor. Among current and former purchasers of the study product, 43.4% of persons who had smoked cigarettes regularly indicated they were motivated to try the product "to help me quit smoking." Only 0.6% of young adult consumers of the nicotine gum (aged 21-30) had not tried tobacco products previously.
Conclusions: Consumer nicotine gum does not appear to attract those who have never used a tobacco product and the results for young adults suggest minimal appeal to youth. The study product was used primarily by individuals who currently smoke and/or use e-cigarettes but who wished to quit or reduce consumption. These results suggest that a consumer nicotine gum may reduce harm by substituting for higher-risk products such as combustible cigarettes.
Keywords: Harm reduction; Nicotine gum; Perception and intention studies; Tobacco.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
CO has received consulting fees from companies to provide summaries of or advice on behavioral science research, including JUUL and Altria. NS has received consulting fees from a number of companies to provide advice and manage projects relating to tobacco product regulatory science. MB has received consulting fees from financial companies to validate their risk models. MB has family ties with one of the LUCY shareholders. KG has received consulting fees from a number of companies to manage projects relating to U.S. FDA applications. WM has received consulting fees from companies in various industries for advice on product regulatory science programs that determine product risks and support U.S. FDA applications.
Figures












Similar articles
-
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Jun 19;6:CD013308. doi: 10.1002/14651858.CD013308.pub2. PMID: 30997928 Free PMC article. Updated.
-
Smokers' behavioral intentions in response to a low-nicotine cigarette policy.Drug Alcohol Depend. 2019 Dec 1;205:107645. doi: 10.1016/j.drugalcdep.2019.107645. Epub 2019 Oct 18. Drug Alcohol Depend. 2019. PMID: 31704376
-
Youths' Perceptions of Nicotine Harm and Associations With Product Use.Nicotine Tob Res. 2023 Jun 9;25(7):1302-1309. doi: 10.1093/ntr/ntad028. Nicotine Tob Res. 2023. PMID: 36920470 Free PMC article.
-
Behavioral intentions assessment of a disposable e-cigarette among adult current, former, and non-smokers in the United States.Drug Test Anal. 2023 Oct;15(10):1233-1256. doi: 10.1002/dta.3467. Epub 2023 Mar 18. Drug Test Anal. 2023. PMID: 36880156
-
Impact of non-menthol flavours in e-cigarettes on perceptions and use: an updated systematic review.BMJ Open. 2019 Oct 16;9(10):e031598. doi: 10.1136/bmjopen-2019-031598. BMJ Open. 2019. PMID: 31619431 Free PMC article.
Cited by
-
Smoking cessation message testing to inform app-based interventions for young adults - an online experiment.BMC Public Health. 2025 May 20;25(1):1852. doi: 10.1186/s12889-025-22995-8. BMC Public Health. 2025. PMID: 40394536 Free PMC article.
-
Effect of fruit and mint flavored Rogue® oral nicotine product use on smoking reduction and quitting in a 6-Month prospective cohort of adults who smoke cigarettes.BMC Public Health. 2024 Nov 22;24(1):3249. doi: 10.1186/s12889-024-20463-3. BMC Public Health. 2024. PMID: 39578809 Free PMC article.
References
-
- Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. 2021;397(10292):2337–2360. - PMC - PubMed
-
- Rosen LJ, Galili T, Kott J, Rees V. Beyond, "Safe and Effective": the urgent need for high-impact smoking cessation medications. Prev Med. 2021;150:106567. - PubMed
-
- Harm Reduction International. What is harm reduction? https://hri.global/what-is-harm-reduction/. Accessed 28 Jul 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical